42
30
Growth Score
-16 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
589261
Clario provides data and technology solutions for clinical trials that collect and analyze data for drug and medical device approvals.
Acquired by 
Thermo Fisher Scientific
- Amit Vasanji: Vice President , Medical & Scientific AffairsPast Role: ImageIQ, Co-Founder & Chief Technology Officer
- Julia James: EVP, Chief Legal and Administrative OfficerPast Role: Thermo Fisher Scientific, Group General Counsel
About the Company
Clario offers a range of technology and services aimed at supporting clinical trials with endpoint data capture, analysis, and evidence generation. They provide tools for cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, respiratory endpoint,s and precision motion, and they integrate these through software, connected
devices, and AI. Their model supports site-based, hybrid, and decentralized trial designs, helping sponsors, biotechs and CROs manage trials across therapeutic areas globally. Their work emphasizes scientific expertise, regulatory compliance across many countries, and a global operational infrastructure.
